Summary
DEVA PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €581k and a net result of €65k. Equity is growing by ~14.2% per year across the filed fiscal years. Its solvency ranks better than 57% of 6157 sector peers (fiscal year 2024). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 01-07-2025, 30 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
30 d early
2023
29 d early
2022
28 d early
2021
20 d early
2020
25 d early
2019
25 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, abbreviated schema
Equity
€581k▲ 6.4%
2023 · €546k
2018: €239klowest in 7 years
2019: €301k▲ +26.2% vs 2018
2020: €370k▲ +22.8% vs 2019
2021: €416k▲ +12.6% vs 2020
2022: €489k▲ +17.5% vs 2021
2023: €546k▲ +11.6% vs 2022
2024: €581k▲ +6.4% vs 2023highest in 7 years
2018 → 2024
Net result
€65k▼ 36.5%
2023 · €102k
2018: €55k
2019: €66k▲ +18.1% vs 2018
2020: €72k▲ +9.4% vs 2019
2021: €50k▼ -29.7% vs 2020lowest in 7 years
2022: €77k▲ +52.7% vs 2021
2023: €102k▲ +33.0% vs 2022highest in 7 years
2024: €65k▼ -36.5% vs 2023
2018 → 2024
Total assets
€980k▼ 2.3%
2023 · €1.00M
2018: €911klowest in 7 years
2019: €944k▲ +3.6% vs 2018
2020: €987k▲ +4.6% vs 2019
2021: €963k▼ -2.5% vs 2020
2022: €980k▲ +1.8% vs 2021
2023: €1.00M▲ +2.4% vs 2022highest in 7 years
2024: €980k▼ -2.3% vs 2023
2018 → 2024
Solvency
59.2%▲ 4.9pp
2023 · 54.4%
2018: 26.2%lowest in 7 years
2019: 31.9%▲ +21.8% vs 2018
2020: 37.5%▲ +17.5% vs 2019
2021: 43.3%▲ +15.4% vs 2020
2022: 49.9%▲ +15.4% vs 2021
2023: 54.4%▲ +8.9% vs 2022
2024: 59.2%▲ +8.9% vs 2023highest in 7 years
2018 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€370k-€416k▲ 12.6%€489k▲ 17.5%€546k▲ 11.6%€581k▲ 6.4%
2020: €370klowest in 5 years
2021: €416k▲ +12.6% vs 2020
2022: €489k▲ +17.5% vs 2021
2023: €546k▲ +11.6% vs 2022
2024: €581k▲ +6.4% vs 2023highest in 5 years
Operating result€110k-€82k▼ 24.9%€123k▲ 49.6%€156k▲ 26.6%€102k▼ 34.4%
2020: €110k
2021: €82k▼ -24.9% vs 2020lowest in 5 years
2022: €123k▲ +49.6% vs 2021
2023: €156k▲ +26.6% vs 2022highest in 5 years
2024: €102k▼ -34.4% vs 2023
Net result€72k-€50k▼ 29.7%€77k▲ 52.7%€102k▲ 33.0%€65k▼ 36.5%
2020: €72k
2021: €50k▼ -29.7% vs 2020lowest in 5 years
2022: €77k▲ +52.7% vs 2021
2023: €102k▲ +33.0% vs 2022highest in 5 years
2024: €65k▼ -36.5% vs 2023
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 34% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €980k
Fixed assets
€907k ▼ 0.1%
Current assets
€73k ▼ 23.4%
Equity and liabilities €980k
Equity
€581k ▲ 6.4%
Provisions
€2k =
Debt
€398k ▼ 12.8%
Debt's share of the balance-sheet total falls from 45.5% to 40.6%. Equity is higher and debt is lower.
Key figures and ratios
ROE
11.2%▼
2023 · 18.8%
ROA
6.6%▼
2023 · 10.2%
Debt ≤ 1 year
€320k▼
2023 · €336k
Debt > 1 year
€78k▼
2023 · €121k
Income taxes
€25k▼
2023 · €42k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 51 lines
Balance sheet
Code20232024
Assets
Total assets20/58€1.00M€980k▼
Fixed assets21/28€908k€907k▼
Tangible fixed assets22/27€8k€7k▼
Land and buildings22€8k€6k▼
Furniture and vehicles24€362€777▲
Financial fixed assets28€900k€900k=
Current assets29/58€96k€73k▼
Amounts receivable within one year40/41€10k€5k▼
Trade receivables40€10k-
Other amounts receivable41-€5k
Cash at bank and in hand54/58€85k€68k▼
Deferred charges and accrued income490/1€483€528▲
Equity and liabilities
Total equity and liabilities10/49€1.00M€980k▼
Equity10/15€546k€581k▲
Contributions10/11€12k€12k=
Reserves13€533k€568k▲
Non-distributable reserves130/1€2k-
Reserves not available under the articles1311€2k-
Distributable reserves133€531k€568k▲
Profit (loss) carried forward14€889€802▼
Provisions and deferred taxes16€2k€2k=
Provisions for liabilities and charges160/5€2k€2k=
Other liabilities and charges164/5€2k€2k=
Amounts payable17/49€456k€398k▼
Amounts payable after more than one year17€121k€78k▼
Financial debts170/4€121k€78k▼
Amounts payable within one year42/48€336k€320k▼
Current portion of amounts payable after more than one year42€42k€43k▲
Trade debts44€195€248▲
Suppliers440/4€195€248▲
Taxes, remuneration and social security45€32k€19k▼
Taxes450/3€32k€19k▼
Other amounts payable47/48€261k€258k▼
Income statement
Code20232024
Non-recurring operating income76A-€70
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€2k▲
Other operating charges640/8€2k€2k▲
Gross operating margin9900€159k€106k▼
Operating profit (loss)9901€156k€102k▼
Financial charges65/66B€12k€12k▲
Recurring financial charges65€12k€12k▲
Profit (loss) for the period before taxes9903€144k€90k▼
Income taxes67/77€42k€25k▼
Profit (loss) for the period9904€102k€65k▼
Profit (loss) for the period to be appropriated9905€102k€65k▼
Appropriation of the result
Profit (loss) to be appropriated9906€103k€66k▼
Profit (loss) brought forward from the previous period14P€888€889▲
Transfer from equity791/2€46k€30k▼
Transfer to equity691/2€102k€65k▼
To other reserves6921€102k€65k▼
Profit to be distributed694/7€46k€30k▼
Return on contributions (dividend)694€46k€30k▼
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €70 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €380 | €917 | €2k | €2k | €2k | ▲ 17.5% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | €30 | €20 | - | - | - |
| Other operating charges640/8 | - | €1k | €1k | €2k | €2k | ▲ 6.6% |
| Gross operating margin9900 | €112k | €85k | €127k | €159k | €106k | ▼ 33.4% |
| Operating profit (loss)9901 | €110k | €82k | €123k | €156k | €102k | ▼ 34.4% |
| Financial charges65/66B | - | €11k | €16k | €12k | €12k | ▲ 3.2% |
| Recurring financial charges65 | €11k | €11k | €16k | €12k | €12k | ▲ 3.2% |
| Profit (loss) for the period before taxes9903 | €99k | €71k | €107k | €144k | €90k | ▼ 37.5% |
| Income taxes67/77 | €27k | €21k | €30k | €42k | €25k | ▼ 40.1% |
| Profit (loss) for the period9904 | €72k | €50k | €77k | €102k | €65k | ▼ 36.5% |
| Transfer from tax-exempt reserves789 | - | €6k | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €72k | €57k | €77k | €102k | €65k | ▼ 36.5% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €987k | €963k | €980k | €1.00M | €980k | ▼ 2.3% |
| Fixed assets21/28 | €901k | €912k | €910k | €908k | €907k | ▼ 0.1% |
| Tangible fixed assets22/27 | €1k | €12k | €10k | €8k | €7k | ▼ 12.8% |
| Land and buildings22 | - | €11k | €9k | €8k | €6k | ▼ 18.6% |
| Furniture and vehicles24 | - | €890 | €626 | €362 | €777 | ▲ 115% |
| Financial fixed assets28 | €900k | €900k | €900k | €900k | €900k | = |
| Current assets29/58 | €86k | €51k | €70k | €96k | €73k | ▼ 23.4% |
| Amounts receivable within one year40/41 | - | - | €15k | €10k | €5k | ▼ 50.0% |
| Trade receivables40 | - | - | €15k | €10k | - | - |
| Other amounts receivable41 | - | - | - | - | €5k | - |
| Cash at bank and in hand54/58 | €85k | €50k | €55k | €85k | €68k | ▼ 20.4% |
| Deferred charges and accrued income490/1 | - | €645 | €448 | €483 | €528 | ▲ 9.2% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €987k | €963k | €980k | €1.00M | €980k | ▼ 2.3% |
| Equity10/15 | €370k | €416k | €489k | €546k | €581k | ▲ 6.4% |
| Contributions10/11 | - | €12k | €12k | €12k | €12k | = |
| Reserves13 | €357k | €403k | €476k | €533k | €568k | ▲ 6.6% |
| Non-distributable reserves130/1 | - | €2k | €2k | €2k | - | - |
| Reserves not available under the articles1311 | - | €2k | €2k | €2k | - | - |
| Distributable reserves133 | - | €401k | €474k | €531k | €568k | ▲ 7.0% |
| Profit (loss) carried forward14 | €742 | €784 | €888 | €889 | €802 | ▼ 9.8% |
| Provisions and deferred taxes16 | €2k | €2k | €2k | €2k | €2k | = |
| Provisions for liabilities and charges160/5 | - | €2k | €2k | €2k | €2k | = |
| Other liabilities and charges164/5 | - | €2k | €2k | €2k | €2k | = |
| Amounts payable17/49 | €615k | €545k | €489k | €456k | €398k | ▼ 12.8% |
| Amounts payable after more than one year17 | €244k | €205k | €163k | €121k | €78k | ▼ 35.8% |
| Financial debts170/4 | - | €205k | €163k | €121k | €78k | ▼ 35.8% |
| Amounts payable within one year42/48 | €371k | €339k | €326k | €336k | €320k | ▼ 4.5% |
| Current portion of amounts payable after more than one year42 | - | €39k | €42k | €42k | €43k | ▲ 1.9% |
| Trade debts44 | €523 | €114 | €115 | €195 | €248 | ▲ 27.2% |
| Suppliers440/4 | - | €114 | €115 | €195 | €248 | ▲ 27.2% |
| Taxes, remuneration and social security45 | - | €23k | €22k | €32k | €19k | ▼ 39.0% |
| Taxes450/3 | - | €23k | €22k | €32k | €19k | ▼ 39.0% |
| Other amounts payable47/48 | - | €277k | €262k | €261k | €258k | ▼ 1.4% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €72k | €50k | €77k | €102k | €65k | ▼ 36.5% |
| + Depreciation and write-downs630 | €380 | €917 | €2k | €2k | €2k | ▲ 17.5% |
| Operating cash flow (approximation) | €72k | €51k | €79k | €104k | €67k | ▼ 35.6% |
| Investment in fixed assets (approximation) | - | €-11k | €0 | €0 | €-983 | - |
| Change in cash | - | €-34k | €5k | €30k | €-17k | ▼ 158% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
01-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2018net €102k ▲33%
Operating result €156k, net result €102k, both a record.
31-12
Financial
Equity above €500kEq €546k ▲11.6%
6 profitable years in a row build equity to €546k.
03-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
11-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Weakest financial yearnet €50k ▼29.7%
Net result drops to €50k, the lowest in the series; recovery starts the following year.
06-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
06-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
23-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
18-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
03-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
19-07
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wielsbeke · 1 establishment unit since 2012
Ground area
2,754 m²
Building footprint
192 m²
Volume, LiDAR
1,117 m³
2 parcels, Flanders · tallest building 9.5 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
DEVA PHARMA
since 20122.211.125.391
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 37017A0423/00G000 | Flanders | 1,473 m² | 1 · 176 m² | 9.5 m · 2 fl. |
| 37017C0151/00H014 | Flanders | 1,281 m² | 1 · 16 m² | 1.9 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
United Mir-Ran
BE 0707.865.715
Antwerpen · Eq €580,784
NBO Management
BE 0842.385.117
Gent · Eq €580,780
TWG Real Estate
BE 0833.746.276
Brugge · Eq €581,036
DD REAL ESTATE
BE 0690.547.552
Sint-Lievens-Houtem · Eq €580,612
Mediwire
BE 0661.686.983
Oostende · Eq €580,572
Of 24,727 companies in sector 64210 we hold annual accounts for 19,768. 13,512 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded03-07-2012
Fiscal year end31-12
Activities, NACEBEL 2025
64210Activities of holding companies
Scores and ratios are computed by Checked and are not a credit decision.